News
ALPMY
17.12
-0.17%
-0.03
Bank of America Securities Sticks to Their Buy Rating for Astellas Pharma (ALPMF)
TipRanks · 3d ago
Weekly Report: what happened at ALPMY last week (1109-1113)?
Weekly Report · 6d ago
AstraZeneca gains additional bladder cancer indication for Imfinzi
Seeking Alpha · 11/13 21:23
Weekly Report: what happened at ALPMY last week (1102-1106)?
Weekly Report · 11/09 09:23
Astellas Pharma (ALPMF) Receives a Hold from Morgan Stanley
TipRanks · 11/05 10:06
Astellas Pharma (ALPMF) Receives a Buy from Macquarie
TipRanks · 11/05 10:05
Astellas Pharma ADR GAAP EPS of v134.47, revenue of ¥1270.86B; updates FY2027 outlook
Seeking Alpha · 11/04 07:38
Here are the major earnings before the open Wednesday
Seeking Alpha · 11/03 23:00
Weekly Report: what happened at ALPMY last week (1026-1030)?
Weekly Report · 11/02 09:23
Weekly Report: what happened at ALPMY last week (1019-1023)?
Weekly Report · 10/26 09:22
AstraZeneca stomach cancer drug doubles survival in late-stage trial
Seeking Alpha · 10/25 16:17
Weekly Report: what happened at ALPMY last week (1012-1016)?
Weekly Report · 10/19 09:23
Macquarie Keeps Their Buy Rating on Astellas Pharma (ALPMF)
TipRanks · 10/16 10:46
Weekly Report: what happened at ALPMY last week (1005-1009)?
Weekly Report · 10/12 09:24
Weekly Report: what happened at ALPMY last week (0928-1002)?
Weekly Report · 10/05 09:24
Astellas Pharma (ALPMF) Gets a Sell from Daiwa
TipRanks · 09/30 12:05
Weekly Report: what happened at ALPMY last week (0921-0925)?
Weekly Report · 09/28 09:23
Weekly Report: what happened at ALPMY last week (0914-0918)?
Weekly Report · 09/21 09:23
Merck Advances European Regulatory Approval For Keytruda Combination In Bladder Cancer
Benzinga · 09/18 16:45
Mizuho Securities Sticks to Their Hold Rating for Astellas Pharma (ALPMF)
TipRanks · 09/14 10:15
More
Webull provides a variety of real-time ALPMY stock news. You can receive the latest news about Astellas Pharma through multiple platforms. This information may help you make smarter investment decisions.
About ALPMY
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.